Dr Robert Ellis

BSc, BHlthSc(Hons), PhD

Clinical Trial Coordinator (TRI, MSH), Lecturer (UQ)

Projects

Princess Alexandra Hospital Kidney Tumour Biobank

SPECTRUM Trial

CKD-TUNED Study

About me

Dr Ellis completed his PhD in 2019 investigating kidney function following nephrectomy for the management of kidney cancer. He is currently a final year medical student and honorary lecturer at the University of Queensland, a clinical research scientist with the Department of Urology at the Princess Alexandra Hospital and manager of the Princess Alexandra Hospital Kidney Tumour Biorepository, and a clinical trial coordinator at the Translational Research Institute working in developing experimental imaging for the investigation of kidney tumours. He is also a visiting scientist at the QIMR Berghofer Medical Research Institute, and is currently the editor-in-chief of the Australian Medical Student Journal.

His research interests encompass the evaluation and improvement of diagnosis and management of kidney diseases and kidney cancer. He has expertise in preclinical and clinical research, epidemiology, and biostatistics.

Publications

Chan S, Marshall MR, Ellis RJ, Ranganathan D, Hawley CM, Johnson DW, Wolley MJ. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study. Nephrol Dial Transplant. 2019. In Press. doi: 10.1093/ndt/gfz160.

Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Neale RE, Wood ST, Jordan SJ. Tumor size and postoperative kidney function following radical nephrectomy. Clin Epidemiol. 2019; 11: 333-348.

Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Marco DJT, Neale RE, Wood ST, Jordan SJ; the IMPROVE Investigators. Incident chronic kidney disease following radical nephrectomy for renal cell carcinoma. Clin Genitourin Cancer. 2019; 17(3): e581-e591.

Shen K, Vesey DA, Ellis RJ, Del Vecchio SJ, Cho Y, Teixeira-Pinto A, McGuckin MA, Johnson DW, Gobe GC. GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma. PloS ONE. 2019; 14(1): e0210246.

Ng KL, Ellis RJ, Samaratunga H, Morais C, Gobe GC, Wood ST. Utility of cytokeratin 7, S100A1 and caveolin 1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Transl Androl Urol. 2019; 8(S2): S123-S137.

Ellis RJ, Kalma B, Del Vecchio SJ, Aliano DN, Ng KL, Dimeski G, Ma L, Guard D, Bertram JF, Morais C, Oliver K, Wood ST, Gobe GC, Francis RS. Chronic kidney cortical damage is associated with baseline kidney function and albuminuria in patients managed with radical nephrectomy for kidney tumours. Pathology. 2019; 51(1): 32-38.

Del Vecchio SJ, Owens EP, Ellis RJ. Kidney cancer biobanking: considerations for a single institutional biorepository. Transl Androl Urol. 2019; 8(S2): S224-S228.

Ellis RJ. Chronic kidney disease after nephrectomy: a clinically-significant entity? Transl Androl Urol. 2019; 8(S2): S166-S174.

Ellis RJ, Edey DP, Del Vecchio SJ, McStea M, Campbell SB, Hawley CM, Johnson DW, Morais C, Jordan SJ, Francis RS, Wood ST, Gobe GC; Cancer Alliance Queensland. End-stage kidney disease following surgical management of kidney cancer. Clin J Am Soc Nephrol. 2018; 13(11): 1641-8.

Del Vecchio SJ, Ellis RJ. Cabozantinib for the management of metastatic clear cell renal cell carcinoma. J Kidney Cancer VHL. 2018; 5(4): 1-5.

Ellis RJ, Del Vecchio SJ, Kalma B, Ng KL, Morais C, Francis RS, Gobe GC, Ferris R, Wood ST. Association between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumours. Int Urol Nephrol. 2018; 50(7): 1211-1217.

Ahn T, Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Hawley CM, Johnson DW, Marco DJT, McStea M, Neale RE, Pascoe EM, Wood ST, Jordan SJ; the IMPROVE Investigators. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis. J Surg Oncol. 2018; 117(7): 1597-1610.

Ellis RJ, Cho Y, Del Vecchio SJ, McStea M, Morais C, Coombes JS, Wood ST, Gobe GC, Francis RS. Outcome measures used to report kidney function in studies investigating surgical management of kidney tumours: a systematic review. Eur Urol Focus. 2018. In Press. doi: 10.1016/j.euf.2018.04.012.

Ellis RJ, Small DM, Ng KL, Vesey DA, Vitetta L, Francis RS, Gobe GC, Morais C. Indoxyl sulfate induces apoptosis and hypertrophy in human kidney proximal tubular cells. Toxicol Pathol. 2018; 46(4): 449-459.

Ellis RJ, Del Vecchio SJ, Ng KL, Owens EP, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. The Correlates of Kidney Dysfunction - Tumour Nephrectomy Database (CKD-TUNED) Study: protocol for a prospective observational study. Asian Pac J Cancer Prev. 2017; 18(12): 3281-3285.

Ellis RJ, Del Vecchio SJ, Ng KL, Dimeski G, Pascoe EM, Hawley CM, Johnson DW, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the CKD-TUNED study. Transl Androl Urol. 2017; 6(5): 899-909.

Ellis RJ, Joshi A, Ng KL, Francis RS, Gobe GC, Wood ST. Optimising assessment of kidney function when managing localised renal masses. Med J Aust. 2017; 207(3): 127-133.

Del Vecchio SJ, Ellis R, Gallagher K, Ng KL, Ma L, Strutton G, Wood S. A rare case of solitary kidney metastasis following primary laryngeal squamous cell carcinoma. J Kidney Cancer VHL. 2017; 4(2): 6-9.

Ellis RJ, Ng KL, Samaratunga H, Del Vecchio SJ, Wood ST, Gobe GC. Multifocal primary neoplasms in kidney allografts: evaluation of two cases. J Kidney Cancer VHL. 2016; 3(2): 14-22.

Ellis RJ, Small DM, Vesey DA, Johnson DW, Francis R, Vitetta L, Gobe GC, Morais C. Indoxyl sulphate and kidney disease: causes, consequences and interventions. Nephrology. 2016; 21(3): 170-177.

Research fields

Nephrology, Urology, Medicine

Connect

ResearcherIDORCIDScopusGoogle Scholar